Safety, tolerability and outcomes of immunotherapy in minority underserved population.

e15004Background: Immune Checkpoint Inhibitors (ICIs) have shown remarkable efficacy, durable responses and prolonged overall survival compared to chemotherapy in many solid tumors. However, most s...